Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized Clinical Investigation of rhBMP-2 and Compression Resistant Matrix With the CD HORIZON® Spinal System for Posterolateral Lumbar Fusion in Patients With Symptomatic Degenerative Disc Disease
Conditions
Interventions
rhBMP-2/CRM/CD HORIZON® Spinal System
Autograft/CD HORIZON® Spinal System
Locations
28
United States
Barrow Neurosurgical Associates
Phoenix, Arizona, United States
Orthopaedic Specialty Institute
Orange, California, United States
UCLA Orthopedic Hospital
Santa Monica, California, United States
Georgetown University Dept. of Orthopaedic Spine Surgery
Washington D.C., District of Columbia, United States
Brevard Orthopaedic Clinic, Inc.
Melbourne, Florida, United States
Florida Ortho Institute
Tampa, Florida, United States
Start Date
March 1, 2002
Primary Completion Date
May 1, 2005
Completion Date
February 1, 2010
Last Updated
May 10, 2023
NCT07127380
NCT07254806
NCT05508360
NCT05037968
NCT05029726
NCT06011551
Lead Sponsor
Medtronic Spinal and Biologics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions